Combined with an integrated staked needle, the new syringe closure system has been designed for use with highly-sensitive compounds such as biologics.
Featuring needle hub and needle shield, the new syringe closure system is partially produced by using a two-component injection molding process of polypropylene and thermoplastic elastomer.
Suitable for silicon-sensitive drug products, the closure system can be used with a wide range of primary packaging options, including different stoppers and glass barrels.
Vetter packaging development director Tilman Roedle said: "Our patented syringe closure system offers pharmaceutical and biotech companies more options for filling highly sensitive parenteral drugs.
"Patients and qualified medical personnel now have the advantage of the system’s easy handling and high standards for product safety and integrity."
Vetter said that it provides complete sterile fill and finish services and helps in the assembly and final packaging of Vetter-Ject syringe systems. The services range from trays and plunger rod assembly to auto-injector assembly and final packaging.
Image: New Vetter-Ject tamper-evident syringe closure system. Photo: courtesy of Vetter.
